Lyra Therapeutics (NASDAQ:LYRA) Given Neutral Rating at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report released on Friday,Benzinga reports. HC Wainwright currently has a $2.00 price objective on the stock. Lyra Therapeutics Stock Down 1.7 % Shares of LYRA stock opened at $0.17 on Friday. The company has a 50 day […]
HC Wainwright reiterated their neutral rating on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report released on Friday,Benzinga reports. HC Wainwright currently has a $2.00 price objective on the stock. Lyra Therapeutics Stock Down 1.7 % Shares of LYRA stock opened at $0.17 on Friday. The company has a 50 day […]
